U.S. markets open in 35 minutes
  • S&P Futures

    4,117.75
    -8.75 (-0.21%)
     
  • Dow Futures

    33,646.00
    -57.00 (-0.17%)
     
  • Nasdaq Futures

    13,743.00
    -51.25 (-0.37%)
     
  • Russell 2000 Futures

    2,180.40
    -3.60 (-0.16%)
     
  • Crude Oil

    61.28
    -1.39 (-2.22%)
     
  • Gold

    1,787.00
    +8.60 (+0.48%)
     
  • Silver

    26.17
    +0.33 (+1.30%)
     
  • EUR/USD

    1.2012
    -0.0029 (-0.24%)
     
  • 10-Yr Bond

    1.5660
    +0.0040 (+0.26%)
     
  • Vix

    18.86
    +1.57 (+9.08%)
     
  • GBP/USD

    1.3908
    -0.0029 (-0.21%)
     
  • USD/JPY

    108.0510
    -0.0190 (-0.02%)
     
  • BTC-USD

    55,452.89
    -805.68 (-1.43%)
     
  • CMC Crypto 200

    1,275.11
    +40.70 (+3.30%)
     
  • FTSE 100

    6,865.69
    +5.82 (+0.08%)
     
  • Nikkei 225

    28,508.55
    -591.83 (-2.03%)
     

Intra-Cellular Therapies to Present at the Evercore ISI 3rd Annual HealthCONx Conference

  • Oops!
    Something went wrong.
    Please try again later.
Intra-Cellular Therapies Inc.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Wednesday, December 2, 2020 at 9:15am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

CONTACT:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
jgrimaldi@burnsmc.com
212-213-0006